A Placebo-Controlled Study of Auxora for the Extended Treatment of High- Risk Patients With Critical COVID-19 Pneumonia
Stopped lack of sufficient numbers of critically ill patients to enroll the study
Conditions
Interventions
- DRUG: Auxora
- DRUG: Placebo
Sponsor
CalciMedica, Inc.